Biotechnology

Helix BioPharma Corp. Announces Delay of Annual Filings

October 15, 2021 8:00 PM

RICHMOND HILL, ON / ACCESSWIRE / October 15, 2021 / Helix BioPharma Corp. (TSX:HBP) ("Helix" or the "Company"), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, announced today that it anticipates the filing of its annual financial statements, management's discussion and analysis, annual information form and related officer certifications for the financial year ended July 31, 2021...

Read more

Apollo Endosurgery Announces Closing of Public Offering and Exercise in Full of Option to Purchase Additional Shares

October 15, 2021 4:05 PM

AUSTIN, TX / ACCESSWIRE / October 15, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, announced today the closing of its previously announced underwritten public offering. Apollo sold 9,660,000 shares of its common stock, including 1,260,000 shares sold pursuant to the underwriters' exercise in full of their option to purchase additional...

Read more

Fuse Science, Inc. Kustomeroo Enters into Partnership with Vanta for SOC 2 & HIPAA Compliance

October 15, 2021 10:00 AM

JACKSONVILLE, FL / ACCESSWIRE / October 15, 2021 / Fuse Science, Inc. (OTC PINK:DROP), Kustomeroo, provider of cloud video contact center solutions, is pleased to announce Kustomeroo has partnered with Vanta to achieve SOC 2 and HIPAA compliance. The partnership will assist in the process of obtaining SOC 2, HIPAA, and giving Kustomeroo the compliance reports needed to meet mandatory requirements large enterprise clients require. Kustomeroo is...

Read more

Oncology Pharma, Inc. Has Engaged a PCAOB Audit Firm Looking Towards Moving the Company Towards a Senior Listing

October 15, 2021 9:57 AM

SAN FRANCISCO, CA / ACCESSWIRE / October 15, 2021 / Oncology Pharma Inc. (OTC PINK:ONPH) Pursuant to previously announced press release, Oncology Pharma, Inc. (the "Company") has retained the services of DBBMcKennon, LLC, a PCAOB Certified Public Accounting Firm. The Company has retained the firm to conduct an audit of its financials in order to become compliant with SEC reporting standards as it look towards its intended NASDAQ Capital Markets...

Read more

SUM, Superior Uptake Method, Launches First THC-V Product Line in Colorado

October 14, 2021 1:00 PM

SUM Microdose CURB and SUM Microdose CONTROL Bring THCV to CO BOULDER, CO / ACCESSWIRE / October 14, 2021 / SUM, Superior Uptake Method, is a unique, fast acting, sugar-free, method to consume cannabis sold in Colorado dispensaries. Its SUM Microdose line of sublingual tablets dissolve under the tongue, bypassing the stomach and letting the cannabinoids avoid the slow and inhospitable journey of being metabolized through the GI tract. Absorbing...

Read more

Applied UV Announces Strategic Acquisition of Scientific Air Management to Accelerate its Growth and Strengthen its Portfolio of High Growth Air Purification Technologies

October 14, 2021 7:00 AM

Scientific Air is expected to contribute approximately $5-7 million in sales to Company's annualized revenues and be immediately accretive to Applied UV's earnings per share Continues the acquisition strategy by Applied UV to acquire and consolidate air and pathogen disinfection industry Company expects to be EBITDA positive during Q1 2022 Product portfolio includes patented 24/7 large air volume, whole room UV-C pathogen killing technology...

Read more

Lexaria's Technology Proven to Deliver Oral THC More Effectively

October 13, 2021 11:00 AM

DehydraTECH delivers equivalent quantity of oral THC three times faster: 15 minutes vs. 45 minutes KELOWNA, BC / ACCESSWIRE / October 13, 2021 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms is pleased to announce that its recent oral tetrahydrocannabinol ("THC") absorption study THC-A21-1 revealed that DehydraTECHTM-THC delivered via oral ingestion required only...

Read more

Hemogenyx Pharmaceuticals Announces CDX Licence Agreement

October 13, 2021 4:10 AM

LONDON, UK / ACCESSWIRE / October 13, 2021 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing new therapies and treatments for blood diseases, announces that it has signed a licence agreement (the "Agreement") with the global biopharmaceutical company Eli Lilly and Company ("Lilly"). Under this Agreement, Lilly grants the Company an exclusive worldwide licence to certain intellectual property developed by Lilly...

Read more

Apollo Endosurgery Announces Pricing of $65 Million Public Offering of Common Stock

October 12, 2021 11:40 PM

AUSTIN, TX / ACCESSWIRE / October 12, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, announced today the pricing of its previously announced underwritten public offering. Apollo is selling 8,400,000 shares of its common stock at a public offering price of $7.75 per share for gross proceeds of approximately $65 million, before deducting...

Read more

Apollo Endosurgery Announces Commencement of Public Offering of Common Stock

October 12, 2021 4:01 PM

AUSTIN, TX / ACCESSWIRE / October 12, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, announced today that it intends to offer and sell shares of its common stock in an underwritten public offering. All of the common stock is being offered by Apollo. In addition, Apollo expects to grant the underwriters a 30-day option to purchase additional...

Read more

Black Bird Biotech Announces Recent In-Field Use of MiteXstreamTM Have Reveled the Potential of MiteXstreamTM As a Biopesticide with Repellent Qualities

October 12, 2021 8:30 AM

FLOWER MOUND, TX / ACCESSWIRE / October 12, 2021 / Black Bird Biotech, Inc. (OTC PINK:BBBT), manufacturer of plant-based MiteXstreamTM biopesticide, announced today that, during recent in-field use of MiteXstreamTM, it has become apparent that MiteXstreamTM is effective in repelling certain pests, including grasshoppers and potato bugs, from plants. With EPA biopesticide certification already in hand, this recent result, which is still to be...

Read more

Rain Bio Appoints Gary Sternberg, MD, MBA as Acting Chief Executive Officer

October 12, 2021 8:00 AM

RALEIGH, NC / ACCESSWIRE / October 12, 2021 / Today, RainBio Inc., a leading developer of novel gene therapies for blinding corneal diseases, announced the appointment of Gary Sternberg, MD, MBA, as its acting chief executive officer. Dr. Sternberg, who has served in various leadership positions in biotech and eye care, brings over 20 years of industry R&D experience to the role. "We're thrilled to welcome Dr. Sternberg to RainBio and look...

Read more

Spotlight Presentation at the World Molecular Imaging Congress Highlights Mosaic ImmunoEngineering's Immuno-Oncology and Modular Vaccine Platform Candidates

October 12, 2021 8:00 AM

Presentation detailed the Company's COVID-19 vaccine candidates that generated antibodies that neutralized SARS-CoV-2 infection of human cells Vaccine candidates hold potential for rapid response to regions that may lack the infrastructure to support traditional temperature-sensitive vaccines NOVATO, CA / ACCESSWIRE / October 12, 2021 / Mosaic ImmunoEngineering Inc. ("Mosaic" or the "Company"), (OTCQB:CPMV), a development-stage biotechnology...

Read more

Oncology Pharma, Inc. Update on PCAOB Audit Selection Process and License Agreement

October 12, 2021 8:00 AM

SAN FRANCISCO, CA / ACCESSWIRE / October 12, 2021 / Oncology Pharma Inc. (OTC PINK:ONPH) Oncology Pharma, Inc. (the "Company") would like to update investors on its progress. The Company is in the final stages of engaging with a PCAOB Audit firm to support its effort to meet one of the necessary steps to qualify for the capital markets tier of the NASDAQ exchange. The Company is committed to complete its process and select a firm to conduct this...

Read more

Announcement from Biovica International's Extra General Meeting

October 12, 2021 7:45 AM

UPPSALA, SE / ACCESSWIRE / October 12, 2021 / Biovica International (STO:BIOVIC-B) (STO:BIOVIC.B) (FRA:9II) The extra general meeting of Biovica International AB ("Biovica" or the "Company") was held today on 12 October 2021 and the following resolutions were passed by the meeting. ELECTION OF THE BOARD OF DIRECTORS The extra general meeting resolved that the board of directors shall consist of eight directors without deputy directors. It was...

Read more

RepliCel Life Sciences Appoints One of Japan's Foremost Regenerative Medicine Industry Business Leaders as Strategic Advisor

October 12, 2021 6:00 AM

Kunihiko Suzuki, one of the leading pioneers in Japan's emerging regenerative medicine industry, commits to a role as Senior Strategic Advisor to RepliCel's Board of Directors VANCOUVER, BC / ACCESSWIRE / October 12, 2021 / RepliCel Life Sciences Inc. (OTC PINK:REPCF)(TSXV:RP)(FRA:P6P2) ("RepliCel" or the "Company"), a company developing next-generation technologies in aesthetics and orthopedics, is pleased to announce that Kunihiko Suzuki has...

Read more

Apollo Endosurgery Announces Preliminary Third Quarter 2021 Financial Results and Provides Business Updates

October 7, 2021 4:05 PM

Revenue expected between $16.0 million and $16.4 million Third consecutive quarter of double-digit revenue growth; endoscopic suturing up over 30% Submitted a De Novo 510(k) Classification Request to FDA for Apollo ESG™ for weight loss and Apollo REVISE™ for prior bariatric surgery revisions Principal investigators expected to present primary efficacy and safety endpoints from MERIT study in late October AUSTIN, TX / ACCESSWIRE / October 7, 2021...

Read more

Black Bird Biotech Launches MiteXstream(TM) Online Store for Direct Sales to Commercial and Home Users

October 7, 2021 8:30 AM

FLOWER MOUND, TX / ACCESSWIRE / October 7, 2021 / Black Bird Biotech, Inc. (OTC PINK:BBBT), manufacturer of plant-based MiteXstreamTM biopesticide, announced today that it has launched an online store for its game-changing biopesticide, MiteXstreamTM, to facilitate direct sales to commercial and home users. The new www.mitexstream.com website has been redesigned to better handle traffic driven to it by BBBT's marketing efforts within the dynamic...

Read more

ITOCO is pleased to present its Carbon Capture Offset program to the upcoming COP26 Conference in Glasgow, United Kingdom.

October 7, 2021 7:45 AM

TORONTO, ON / ACCESSWIRE / October 7, 2021 / ITOCO INC. (OTC Pink:ITMC) ITOCO representatives will be presenting to and attending the meeting session COP 26, Glasgow, UK, from 25 Oct 2021 to 12 Nov 2021. COP26 is the annual United Nations Climate Change Conference. It is the largest Conference of its type in the world. The climate talks will be the largest international summit ever held in the UK, bringing together heads of state, climate...

Read more

Mosaic ImmunoEngineering Expands Immuno-Oncology Platform Through New Technology Licensing Agreement with the University of California San Diego

October 6, 2021 8:00 AM

- Nanoparticle-based technology complements the company's intratumoral technology platform - NOVATO, CA / ACCESSWIRE / October 6, 2021 / Mosaic ImmunoEngineering, Inc. ("Mosaic" or the "Company"), (OTCQB:CPMV), a development-stage biotechnology company focused on bridging immunology and engineering to develop novel immunotherapies to treat and prevent cancer and infectious diseases, today announced that it has licensed rights to develop and...

Read more